53
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Emollient therapy in atopic dermatitis

Pages S19-S21 | Published online: 12 Jul 2009
 

Abstract

Atopic dermatitis (atopic eczema) has shown a marked increase in the last decade, affecting 10-15% of children. The clinical presentation is that of an itchy, dermatitic, dry skin which results from immunological dysfunction and includes changes in the noninvolved skin. These alterations include increased itchiness, morphological change, low sebum production, disturbance in water exchange correlated with impaired barrier function, loss of vascular regulation, and secondary staphylococcal colonization. The management of the disease includes both general and topical measures: moisturizers or emollients, antibacterial treatment and cortico-teroids. Humectants are widely used in emollients to increase or maintain the water content in the stratum corneum. The efficacy of emollients may be assessed by clinical and noninvasive methods which determine their effect on skin hydration or barrier function. It is clear that emollients have an important role in improving skin dryness, particularly in atopic dermatitis, often reducing the need for topical corticosteroids. In conclusion, emollients should be used prophylactically, as well as therapeutically, provided they are cosmetically acceptable to the patient and are used frequently.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.